Search for: "Kaisa v. Chang" Results 41 - 60 of 74
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
The five categories of green technologies listed by the BRPTO are: (i) alternative energies; (ii) transportation; (iii) energy conservation; (iv) waste management; and (v) sustainable agriculture. [read post]
These were two of the key questions which the Court of Appeal grappled with in Thaler v Comptroller General of Patents [2021] EWCA Civ 1374. [read post]
These were two of the key questions which the Court of Appeal grappled with in Thaler v Comptroller General of Patents [2021] EWCA Civ 1374. [read post]
9 Feb 2023, 7:00 am by Eden Winlow (Bristows)
  Within the framework of these meetings, technical proposals called “Tdocs” are submitted for new aspects of the standard or for proposed changes to existing aspects of the standard. [read post]
6 Dec 2018, 12:21 am by Kluwer Patent blogger
Here are the main changes and what they mean for users of the European patent system. [read post]
16 Apr 2021, 1:05 am by Kluwer Patent blogger
(b) Will the reference point for inventiveness or obviousness need to be changed? [read post]
17 Nov 2023, 6:00 am by Gregory Bacon (Bristows)
Multiple parallel cases This was an interesting feature of the Ocado v AutoStore litigation. [read post]
9 Sep 2020, 7:01 am by Roya Ghafele (OxFirst)
Earlier versions of the doctrine can already be found in 1610 in the case of Vernor v Elvies. [read post]
22 Feb 2023, 4:47 am by Brian Cordery (Bristows)
This would include discussions with the relevant individuals relating to technical changes or non-infringing design-arounds to be implemented. [read post]
23 Dec 2020, 10:07 pm by Kluwer Patent blogger
In tenth position is an blogpost discussing a case in India: Monsanto v. [read post]
11 Jul 2019, 10:20 am by Miquel Montañá
This argument must be rejected outright, as when SCA filed its opposition it was defending its interests as competitor of the party which at the time was the patent owner, but logically, after acquiring the patent rights, its interests changed. 12. [read post]
Another topic to evaluate is how patent protection strategies are pursued in parallel to clinical and commercial activities related to COVID-19 vaccines, diagnostics, and therapeutics (for example, the authors of a recent Lancet paper about the Sputnik V vaccine are named as inventors in a series of Russian patent documents published between May and September 2020 and in a PCT application published in January 2021). [read post]